ProGenis Pharmaceuticals is excited to announce our sponsorship of the First Nucleic Acid Therapeutics Regional… Read More »ProGenis Pharmaceuticals Proudly Sponsors the First Nucleic Acid Therapeutics Regional Meeting – India 2025
ProGenis Pharmaceuticals is proud to have been one of the sponsors for the incredible Spotlight on… Read More »Celebrating WA’s Thriving Life Sciences Sector: A Night to Remember
ProGenis Pharmaceuticals marked a significant milestone—its first anniversary—by hosting a memorable event that brought together… Read More »Celebrating a Year of Innovation: ProGenis Pharmaceuticals Anniversary Event
ProGenis Pharmaceuticals is proud to welcome Professor Girish Dwivedi as its new Clinical Advisor for… Read More »ProGenis Pharmaceuticals Welcomes Professor Girish Dwivedi as Clinical Advisor for Cardiovascular Diseases
The streets of Perth turned vibrant this morning as thousands of participants gathered for the… Read More »ProGenis Pharmaceuticals Runs for a Reason at the Annual 2024 HBF Run: Supporting the Australian Coeliac Association
ProGenis Pharmaceuticals is delighted to announce the appointment of Professor Bu Yeap as its new… Read More »ProGenis Pharmaceuticals Welcomes Professor Bu Yeap as Clinical Advisor for Metabolic Diseases
A new chapter in groundbreaking health research has begun with the official launch of ProGenis Pharmaceuticals,… Read More »WA Pharma Startup ProGenis Pharmaceuticals Aims to Revolutionise Diabetes and Rare Disease Treatment
In an exciting new collaboration, ProGenis Pharmaceuticals has entered into a Patent Assignment Agreement with… Read More »ProGenis Pharmaceuticals Partners with Murdoch University to Develop Groundbreaking Treatment for Duchenne Muscular Dystrophy
ProGenis Pharmaceuticals, a leader in innovative scientific solutions, is proud to announce the appointment of… Read More »ProGenis Pharmaceuticals Welcomes Dr. Sudhir Agrawal as its Chair of the Scientific Advisory Board